Non-megaloblastic (Liver disease, Alcohol, Reticulocytosis)

Summary

Non-megaloblastic macrocytic anemia is a group of anemias in which the mean corpuscular volume (MCV) is high (> 100 fL) but DNA synthesis is normal. The red cells become large because of extra membrane lipid or because of a young red cell population (reticulocytosis) — not because of vitamin B12 or folate deficiency.

The three classic causes you must know are:

• Chronic liver disease (most common in clinical practice).
• Chronic alcohol use (direct toxic effect on the marrow).
• Reticulocytosis (the marrow is responding to hemolysis or recent blood loss).

Other less common causes include hypothyroidism and certain drugs (e.g., zidovudine, hydroxyurea). The peripheral smear typically shows round macrocytes (not the oval ones seen in B12/folate deficiency) and no hypersegmented neutrophils. Treatment is directed at the underlying cause.

Definition

• Macrocytic anemia = anemia with MCV > 100 fL.
• Megaloblastic = caused by impaired DNA synthesis (B12 or folate deficiency, antimetabolite drugs). Smear shows oval macrocytes + hypersegmented neutrophils.
• Non-megaloblastic = MCV is high but DNA synthesis is normal. The macrocytosis comes from:
  • excess red-cell membrane lipid (liver disease, alcohol, hypothyroidism), or
  • release of large young red cells / reticulocytes after hemolysis or bleeding.
• Smear shows round macrocytes with no hypersegmented neutrophils.

Etiology

The causes are easier to remember if you split them into three mechanisms: (1) extra lipid in the red cell membrane, (2) too many young red cells in circulation, and (3) drugs / marrow disorders.

Pathophysiology

1. Liver disease

• The diseased liver alters lipid metabolism → cholesterol and phospholipids deposit on the RBC membrane.
• The membrane surface area increases → RBC becomes large and round.
• If cholesterol is selectively increased → target cells (codocytes).
• In severe end-stage liver disease → spur cells (acanthocytes), which are removed by the spleen and cause hemolysis.

2. Alcohol

• Direct toxic effect of ethanol/acetaldehyde on erythroid precursors in the bone marrow.
• Macrocytosis can appear even without anemia and even with normal B12/folate — a useful marker of chronic alcohol use.
• Alcoholics often also have folate deficiency (poor diet) → can develop a mixed megaloblastic picture.

3. Reticulocytosis

• Reticulocytes are ~20% larger than mature RBCs.
• When the marrow releases many of them (after hemolysis or bleeding), the average cell size (MCV) rises.
• This is a physiologic, appropriate macrocytosis — not a true marrow disease.

Clinical Features

Patients usually present with features of the underlying disease more than the anemia itself, because the anemia is typically mild and develops slowly.

General anemia symptoms

• Fatigue, weakness, pallor.
• Exertional dyspnea, palpitations (only if Hb is significantly low).
• No neurological symptoms (this is a key point that separates it from B12 deficiency).
• No glossitis (which is seen in megaloblastic anemia).

Clues to the cause

• Liver disease: jaundice, ascites, spider angiomas, palmar erythema, gynecomastia, splenomegaly.
• Alcoholism: history of heavy drinking, signs of liver disease, peripheral neuropathy (from thiamine deficiency, not B12), tremor.
• Hemolysis: jaundice, dark urine, splenomegaly, family history of anemia.
• Hypothyroidism: cold intolerance, constipation, weight gain, bradycardia, dry skin.
• MDS: elderly patient, fatigue, bleeding, recurrent infections (pancytopenia).

Diagnosis

Step 1 — Confirm macrocytic anemia

• CBC: Hb low, MCV > 100 fL.
• Macrocytosis is usually mild (MCV 100–110 fL); very high values (>115) point more to megaloblastic causes.

Step 2 — Reticulocyte count

• High reticulocytes → think hemolysis or blood loss (cause of macrocytosis is the young cells themselves).
• Low / normal reticulocytes → think liver, alcohol, hypothyroid, drugs, MDS.

Step 3 — Peripheral blood smear

• Round macrocytes → non-megaloblastic.
• Oval macrocytes + hypersegmented neutrophils → megaloblastic (B12/folate).
• Target cells → liver disease.
• Spur cells (acanthocytes) → severe/end-stage liver disease.
• Polychromasia → reticulocytosis.

Step 4 — Cause-specific workup

• B12 and folate levels — must be checked to rule out megaloblastic anemia (always normal in pure non-megaloblastic).
• LFTs (AST, ALT, bilirubin, albumin, PT/INR) — liver disease.
• GGT, AST:ALT ratio > 2 — alcoholic liver disease.
• TSH — hypothyroidism.
• Hemolysis screen: LDH↑, indirect bilirubin↑, haptoglobin↓, Coombs test.
• Bone marrow biopsy — if MDS is suspected (elderly + pancytopenia).

Peripheral Smear Findings

The blood smear is the fastest way to separate the causes of non-megaloblastic macrocytic anemia. Recognize these four pictures:

• Target cells (codocytes) — central "bulls-eye" appearance; classic for chronic liver disease and also seen in thalassemia and post-splenectomy.
• Acanthocytes (spur cells) — irregular thorny projections; seen in end-stage liver disease.
• Echinocytes (burr cells) — regular small spikes; seen in uremia and liver disease.
• Polychromasia — large bluish-grey RBCs (reticulocytes); indicates active marrow response as in hemolysis or recent bleeding.

Differential Diagnosis

When you see a high MCV, work through this short list:

1. Megaloblastic anemia (B12 / folate deficiency) — must always be ruled out first. Look for oval macrocytes, hypersegmented neutrophils, very high MCV, neuro symptoms (B12).
2. Liver disease — abnormal LFTs, target cells, signs of cirrhosis.
3. Alcoholism — history, AST > ALT, raised GGT and MCV even before anemia develops.
4. Reticulocytosis — high retic count, polychromasia, raised LDH and bilirubin, low haptoglobin (hemolysis).
5. Hypothyroidism — high TSH, low T4.
6. Drug-induced — review medications (AZT, hydroxyurea, phenytoin, methotrexate).
7. Myelodysplastic syndrome — elderly, pancytopenia, dysplastic cells on smear/marrow.

Management

There is no specific drug for non-megaloblastic macrocytic anemia. The principle is simple: treat the underlying cause.

• Liver disease: treat the cause (stop alcohol, treat viral hepatitis, manage cirrhosis complications). Macrocytosis usually persists as long as the liver disease is active.
• Alcohol: abstinence is the main treatment. MCV normalizes over ~2–4 months after stopping. Give thiamine first (to prevent Wernicke), then folate if deficient.
• Reticulocytosis (hemolysis / blood loss): identify and treat the cause of hemolysis or bleeding. The macrocytosis disappears once the marrow response settles.
• Hypothyroidism: levothyroxine; MCV normalizes with treatment.
• Drug-induced: stop or reduce the offending drug if possible; otherwise accept it as a known side effect.
• MDS: hematology referral — supportive care, transfusions, erythropoietin, hypomethylating agents (azacitidine), or stem-cell transplant for selected patients.

Supportive measures

• Transfusion only if symptomatic anemia or Hb < 7 g/dL.
• Always replace folate in alcoholics and pregnant patients to prevent a coexisting megaloblastic component.
• Counsel about nutrition and alcohol cessation.

Complications

The complications come mainly from the underlying disease, not from the anemia itself.

• Liver disease: progression to cirrhosis, portal hypertension, variceal bleeding, hepatic encephalopathy, hepatocellular carcinoma. Spur-cell hemolysis carries a poor prognosis.
• Alcohol: Wernicke-Korsakoff syndrome, pancreatitis, cardiomyopathy, alcoholic liver disease.
• Chronic hemolysis: gallstones (pigment stones), splenomegaly, iron overload (if repeatedly transfused).
• MDS: progression to acute myeloid leukemia (AML) in ~30% of cases.
• Severe anemia: high-output heart failure (rare, only with very low Hb).